Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

References for PMC Articles for PubMed (Select 21926283)

1.

Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy.

Grunfeld C, Saag M, Cofrancesco J Jr, Lewis CE, Kronmal R, Heymsfield S, Tien PC, Bacchetti P, Shlipak M, Scherzer R; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM).

AIDS. 2010 Jul 17;24(11):1717-26. doi: 10.1097/QAD.0b013e32833ac7a2.

2.

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.

Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O'Donnell CJ, Fox CS.

Hepatology. 2010 Jun;51(6):1979-87. doi: 10.1002/hep.23593.

3.

The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers.

Pao VY, Lee GA, Taylor S, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C.

AIDS. 2010 Jan 16;24(2):265-70. doi: 10.1097/QAD.0b013e328333af1c.

PMID:
19890203
4.

Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men.

Frederiksen L, Nielsen TL, Wraae K, Hagen C, Frystyk J, Flyvbjerg A, Brixen K, Andersen M.

J Clin Endocrinol Metab. 2009 Oct;94(10):4010-5. doi: 10.1210/jc.2009-0980. Epub 2009 Sep 15.

PMID:
19755479
5.

Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.

Gerschenson M, Kim C, Berzins B, Taiwo B, Libutti DE, Choi J, Chen D, Weinstein J, Shore J, da Silva B, Belsey E, McComsey GA, Murphy RL.

J Antimicrob Chemother. 2009 Jun;63(6):1244-50. doi: 10.1093/jac/dkp100. Epub 2009 Mar 25.

6.

Prevalence of dyslipidemia and dysglycaemia in HIV infected patients.

Manuthu EM, Joshi MD, Lule GN, Karari E.

East Afr Med J. 2008 Jan;85(1):10-7.

PMID:
18543521
7.

Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study.

Grunfeld C, Rimland D, Gibert CL, Powderly WG, Sidney S, Shlipak MG, Bacchetti P, Scherzer R, Haffner S, Heymsfield SB.

J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):283-90.

8.

Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy.

Mutimura E, Stewart A, Rheeder P, Crowther NJ.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):451-5.

PMID:
18077834
9.

Relationship of fat distribution with adipokines in human immunodeficiency virus infection.

Kosmiski LA, Bacchetti P, Kotler DP, Heymsfield SB, Lewis CE, Shlipak MG, Scherzer R, Grunfeld C.

J Clin Endocrinol Metab. 2008 Jan;93(1):216-24. Epub 2007 Oct 16.

10.

Abnormal glucose metabolism among older men with or at risk of HIV infection.

Howard AA, Floris-Moore M, Lo Y, Arnsten JH, Fleischer N, Klein RS.

HIV Med. 2006 Sep;7(6):389-96.

11.

The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics.

Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, Grunfeld C.

Am J Epidemiol. 2006 May 1;163(9):860-9. Epub 2006 Mar 8.

12.

Fat distribution in men with HIV infection.

Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, Saag M, Scherzer R, Shlipak M, Tien P; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM).

J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):121-31.

13.

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.

Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS.

Arch Intern Med. 2005 May 23;165(10):1179-84. Erratum in: Arch Intern Med. 2005 Nov 28;165(21):2541.

PMID:
15911733
14.

Disorders of glucose metabolism among HIV-infected women.

Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Fleischer N, Lo Y, Schoenbaum EE.

Clin Infect Dis. 2005 May 15;40(10):1492-9. Epub 2005 Apr 11.

15.

Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study.

Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, Kritchevsky SB, De Rekeneire N, Kanaya AM, Newman AB, Tylavsky FA, Seidell JC; Health ABC Study.

Diabetologia. 2005 Feb;48(2):301-8. Epub 2005 Jan 20.

PMID:
15660262
16.

Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors.

Jericó C, Knobel H, Montero M, Ordoñez-Llanos J, Guelar A, Gimeno JL, Saballs P, López-Colomés JL, Pedro-Botet J.

Diabetes Care. 2005 Jan;28(1):132-7.

PMID:
15616246
17.

Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study.

Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, Heine RJ, Nijpels G, Seidell JC; Hoorn study.

Diabetes Care. 2004 Feb;27(2):372-7.

PMID:
14747216
18.

Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study.

Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH, Kronmal RA, Resnick HE, Psaty BM.

Arch Intern Med. 2002 Jan 28;162(2):209-16.

PMID:
11802755
19.

Metabolic effects of indinavir in healthy HIV-seronegative men.

Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen RA, Schambelan M, Grunfeld C.

AIDS. 2001 May 4;15(7):F11-8.

20.

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

Behrens G, Dejam A, Schmidt H, Balks HJ, Brabant G, Körner T, Stoll M, Schmidt RE.

AIDS. 1999 Jul 9;13(10):F63-70.

PMID:
10416516
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk